Keith R. Fluegge

Mr. Keith R. Fluegge

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 January 2018 in Neurochemistry International
Verified
Journal Article
Closed access
KFKeith R. Fluegge
Keith R. Fluegge
KFKyle Fluegge
Kyle Fluegge

1 June 2017 in Environment International
Verified
Journal Article
Closed access
KFKeith R. Fluegge
Keith R. Fluegge
KFKyle Fluegge
Kyle Fluegge

8 March 2016 in Journal of Attention Disorders
Verified
Journal Article
Closed access
PDF file
KFKeith R. Fluegge
Keith R. Fluegge
Objective: In their meta-analysis, Adeyemo et al. reported a strong association between mild traumatic brain injury (mTBI) and ADHD. However, less is understood about why such an association exists. Method: This commentary focuses on the underlying etiologies of both conditions to reveal potential toxic synergisms that could explain this association. Results: Alcohol and substance abuse are recognized comorbidities in both conditions. The author of this commentary has recently been the first to propose that chronic exposure to nitrous oxide (N2O), an increasing environmental air pollutant and greenhouse gas, may contribute to the cognitive impairment seen in conditions such as ADHD and autism. The toxic synergisms from combined GABA-mimetics, such as ethanol, and nontoxic N2O exposure have been previously elucidated and are further contextualized here. Conclusion: The conclusion of this commentary is that the toxicological interdependence of the underlying etiologies for mTBI and ADHD may help to explain their association as found in the meta-analysis conducted by Adeyemo et al. This commentary explores this dynamic further and, in so doing, underscores the need for additional research to validate these important conclusions.

26 April 2016 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
KFKeith R. Fluegge
Keith R. Fluegge
A reply to ‘Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study’

1 January 2019 in Alzheimer's & Dementia: Translational Research & Clinical Interventions
Verified
Journal Article
Open access
KFKeith R. Fluegge
Keith R. Fluegge
Introduction: Dysregulated lipid metabolism and nutrient status are thought to play a role in the pathophysiology of Alzheimer's disease (AD). However, the precise involvement is not well understood, and it remains unclear exactly how such dysregulated lipid metabolism and altered nutrient status, especially changes in phosphatidylcholine, B12, and folate, are connected to the hallmark pathology in AD (i.e., amyloidogenesis). Methods: We have postulated that genetic susceptibility (i.e., APOE ε4/ε4) to environmental exposure to emissions of nitrous oxide (N 2 O) could underlie the onset of AD and its early neuropsychiatric correlates Results and Discussion: The current theoretical editorial describes, using clinical, preclinical, and in vitro evidences, how this model contributes not only to amyloidogenesis but also other nonopioid effects, specifically altered lipid metabolism, depletion of vitamin B12, and disruption of the folate‐mediated one carbon metabolic pathway.